D-0875-2026 Class II Ongoing
FDA drug recall D-0875-2026 was initiated by TerSera Therapeutics LLC on Aug 31, 2026 and is designated Class II. Reason for recall: Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours. The recall status is ongoing. Affected quantity: 296 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 7, 2026
- Initiation Date
- Aug 31, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 296 cartons
Product Description
Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.
Reason for Recall
Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
Distribution Pattern
USA Nationwide
Code Information
Lot#: YN0099, Exp 01/31/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0875-2026
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026